Drug-induced toxic epidermal necrolysis with involvement of the intestinal and respiratory tract. A case report;Toxisch epidermale nekrolyse: Arzneimittelinduzierte toxisch epidermale nekrolyse mit beteiligung des intestinal- und respirationstraktes

Anaesthesist

Volumn 51, Issue 10, 2002, Pages 815-819

  Jackel R ^a   Fuchs, M ^a   Raff, T ^a   Wiedemann, B ^a  

^a Klinikum St Georg   (Germany)

Author keywords

Intestinal lesions; Lyell syndrome; Sepsis; Toxic epidermal necrolysis; Tracheostenosis

Indexed keywords

ALLOPURINOL; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; CARBAMAZEPINE; GLUCOCORTICOID; IMMUNOGLOBULIN; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; CASE REPORT; CONVALESCENCE; DISEASE SEVERITY; DRUG INDUCED DISEASE; ENTEROPATHY; HEALTH CARE FACILITY; HUMAN; INCIDENCE; INTENSIVE CARE; LARYNGOTRACHEOBRONCHITIS; LARYNX STENOSIS; LONG TERM CARE; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; PSORIASIS; RESPIRATORY TRACT DISEASE; SEPSIS; SKIN DEFECT; TOXIC EPIDERMAL NECROLYSIS; WOUND HEALING;

ALCOHOLISM; ANTICONVULSANTS; BURN UNITS; CARBAMAZEPINE; EPIDERMAL NECROLYSIS, TOXIC; HUMANS; INTESTINAL DISEASES; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; RESPIRATORY TRACT DISEASES; SKIN;

EID: 0036809512     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00101-002-0404-8     Document Type: Article

References (37)

1. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864-874
2. Barrera JE, Meyers AD, Hartford EC (1998) Hypopharyngeal stenosis and dysphagia complicating toxic epidermal necrolysis. Arch Otolaryngol Head Neck Surg 124:1375-1376
3. Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC (1993) Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnsons syndrome, and erythema multiforme. Arch Dermatol 129:92-96
4. Bastuji-Garin S, Zahedi M, Guillaume JC, Roujeau JC (1993) Toxic epidermal necrolysis (Lyell syndrome) in 77 eldery patients. Age Ageing 22:450-456
5. Becker DS (1998) Toxic epidermal necrolysis. Lancet 351:1417-1420
6. Blum L, Chosidow O, Rostoker G et al. (1996) Renal involvement in toxic epidermal necrolysis. J Am Acad Dermatol 34:1088-1090
7. Bradley T, Brown RE, Kucan JO, Smoot EC III, Hussmann J (1995) Toxic epidermal necrolysis: A review and report of the successful use of Biobrane for early wound coverage. Ann Plast Surg 35:124-132
8. Chosidow O, Delchier JC, Chaumette MT et al. (1991) Intestinal involvement in drug-induced toxic epidermal necrolysis. Lancet 337:9289
9. Egan CA, Grand WJ, Morris SE, Saffle JR, Zone JJ (1999) Plasmapherese as an adjunct treatment in toxic epidermal necrolysis. J Am Acad Dermatol 40:458-461
10. Furubacke A, Berlin G, Anderson C, Sjöberg F (1999) Lack of significant effect of plasma exchange in the treatment of drug-induced toxic epidermal necrolysis. Intensive Care Med 25:1307-1310
11. Green D, Law E, Still JM (1993) An approach to the management of toxic epidermal necrolysis in a burn centre. Burns 61:411-414
12. Halebian PH, Shires GT (1989) Burn unit treatment of acute, severe exfoliating disorders. Ann Rev Med 40:137-147
13. Heimbach DM, Engrav LH, Marvin JA, Harnar TJ, Grube BJ (1987) Toxic epidermal necrolysis: A step forward in treatment. JAMA 257:2171-2175
14. Hermes B, Haas N, Henz BM (1996) Plasmapherese und immunpathogenetische aspekte bei der toxischen epidermalen nekrolyse. Hautarzt 47:749-753
15. Ivor RA, Zaidi J, Peters WJ, Hyland RH (1996) Acute and chronic respiratory complications of toxic epidermal necrolysis. J Burn Care Rehabil 17:237-240
16. Kelemen JJ III,Cioffi WG, McManus WF, Mason AD Jr, Pruitt BA Jr (1995) Burn center care for patients with toxic epidermal necrolysis. J Am Coll Surg 180:273-278
17. Khoo AKM, Foo CL (1996) Toxic epidermal necrolysis in a burn centre: A 6-year review. Burns 22:275-278
18. McGee T, Munster A (1998) Toxic epidermal necrolysis syndrome: Mortality rate reduced with early referral to regional burn center. Plast Reconstr Surg 102:1018-1022
19. Mockenhaupt M, Schöpf E (1996) Epidemiology of drug-induced severe skin reactions. Sem Cutan Med Surg 15:236-243
20. Murphy TJ, Purdue GF, Hunt JL (1997) Toxic epidermal necrolysis. J Burn Care Rehabil 18:417-420
21. Pace J, Adami JZ, Mallia C, Mizzi A (1999) Toxic epidermal necrolysis in a patient with psoriatic arthritis. Adv Exp Med Biol 445:557-560
22. Parsons JM (1992) Toxic epidermal necrolysis. Int J Dermatol 31:749-768
23. Pasmans SGMA, Bruijnzeel-Koomen CAFM, Reijsen FC van (1999) Skin reactions to carbamazepine. Allergy 54:643-650
24. Petter G, Haustein UF (1999) Stevens-Johnson-Syndrom mit übergang in eine toxisch epidermale nekrolyse nach carbamazepin-einnahme, heroin- und alkoholabusus. Hautarzt 50:884-888
25. Revuz J, Roujeau JC, Guillaume JC, Penso D, Touraine R (1987) Treatment of toxic epidermal necrolysis: Creteil's experience (editorial). Arch Dermatol 123:1156-1158
26. Roujeau JC, Kelly JP, Naldi Let al.(1995) Medication use and the risk of Stevens-Johnsons syndrome or toxic epidermal necrolysis. N Engl J Med 333:1600-1607
27. Roupe G, Ahlmen M, Fagerberg B, Suurküla M (1986) Toxic epidermal necrolysis with extensive mucosal erosions of the gastrointestinal and respiratory tracts. Int Arch Allergy Appl Immunol 80:145-151
28. Rzany B, Hering O, Mockenhaupt M, Schröder W, Goerttler E, Ring J, Schöpf (1996) Histopathological and epidemiological characteristics of patients with erythema exudativum multiforme major, Stevens-Johnson syndrome and toxic epidermal necrolysis. Br J Dermatol 135:6-11
29. Rzany B, Mockenhaupt M, Baur S et al. (1996) Epidemiology of erythema exudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990-1992): Structure and results of population-based registry. J Clin Epidemiol 49:769-773
30. Schwartz RA (1997) Toxic epidermal necrolysis. Cutis 59:123-128
31. Sugimoto Y, Mizutani H, Sato T, Kawamura N, Ohkouchi K, Shimizu M (1998) Toxic epidermal necrolysis with severe gastrointestinal mucosal cell death: A patient who excreted long tubes of dead intestinal epithelium. J Dermatol 25:533-538
32. Viard I, Wehrli P, Bullani R et al. (1998) Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 282:490-493
33. Wahle D, Beste DJ, Conley SF (1992) Laryngeal involvement in toxic epidermal necrolysis. Otolaryngol Head Neck Surg 107:796-800
34. Wolkenstein PE, Roujeau JC, Revuz J (1998) Drug-induced toxic epidermal necrolysis. Dermatol Clin 16:399-409
35. Wong KC, Kennedy PJ, Lee S (1999) Clinical manifestation and outcomes in 17 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis. Australas J Dermatol 40:131-134
36. Yarbrough DR (1996) Experience with toxic epidernmal necrolysis treated in a burn center. J Burn Care Rehabil 17:30-33
37. Zoltie N, Verlende P, O'Neill TJ, McKenzie AW (1994) Lyell's syndrome on a burn unit. Burns 20:368-370